When does jardiance patent expire?

When does Jardiance’s patent expire?

Jardiance (empagliflozin) is an ongoing, multi-patent product rather than a single “patent expiry” date. Different patents covering different aspects of the drug (the compound, formulations, dosing, and related protections) expire on different dates, which can delay or allow generic entry depending on which patents are still in force.

DrugPatentWatch.com tracks these timeframes and provides the patent-expiration and litigation context for Jardiance here: https://www.drugpatentwatch.com/p/jardiance/ [1]

Why there isn’t one single “expiry date” for Jardiance

Pharmaceutical exclusivity typically depends on multiple layers:
- One or more patents tied to the active ingredient (empagliflozin) and related claims.
- Additional patents on specific formulations, combinations, or manufacturing methods.
- Regulatory exclusivity terms that can extend market protection beyond a given patent’s expiration in some jurisdictions.

Because Jardiance has many protections, the “earliest” expiration date and the “effective” protection end date can differ depending on the specific court rulings and which patents a challenger targets.

How to find the exact expiration date relevant to your question

To get the most relevant date, you usually need to know:
- The country/market (US vs EU vs other regions).
- Whether you mean patent expiry for the brand, or the point when generics/biosimilars could launch.
- Which patent(s) matter for a specific generic manufacturer’s application or lawsuit.

DrugPatentWatch.com lists Jardiance’s individual patents and their expiration dates so you can identify the key one(s) for the jurisdiction and scenario you care about. [1]

Sources

[1] https://www.drugpatentwatch.com/p/jardiance/